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Abstract  The  standard  breast  MRI  protocol  includes  T2  sequences  (anatomy  and  signal  anal-
ysis), T1  gradient-echo  sequences  which  can  detect  markers  placed  after  biopsy,  and  injected
dynamic 3D  sequences  for  performing  volume  and  multiplanar  reconstructions,  which  are  par-
ticularly useful  for  locating  lesions  well.  Good  patient  positioning  is  essential  and  is  obtained
by using  foam  wedges  for  small  breasts,  ensuring  there  are  no  folds,  and  the  correct  position
of the  nipples.  These  aspects  limit  movement  artefacts  which  alter  subtraction  sequences,  so
that it  must  always  be  possible  for  reading  these  sequences  to  be  assisted  by  comparing  them
with the  native  sequences.  New  functional  imaging  sequences  are  now  appearing  in  an  attempt
to increase  the  speciﬁcity  of  MRI,  which  is  one  of  its  main  limitations.  Of  these,  magnetic  reso-
nance spectroscopy  appears  to  be  the  most  promising,  highlighting  an  abnormal  choline  peak  in
malignant lesions.  This  molecular  signature  provides  early  information  (24  hours  after  beginning
neoadjuvant  treatment)  on  the  chemosensitivity  of  a  breast  tumour.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Breast  MRI  has  become  an  essential  examination  for  investigating  the  pathological
breast.  Over  the  past  10  years  or  so,  a  number  of  papers  have  described  good  practice
in  performing  this  examination  [1,2]. Breast  MRI  is  the  imaging  of  tumour  angiogenesis,
based  on  studying  dynamic  uptake  of  contrast  agent  in  T1  imaging,  which  varies  with
the  microvascularisation  characteristics  of  breast  tumours.  At  the  beginning  of  the  1990s,
there  were  two  opposite  approaches  in  the  literature:  some  authors  advocated  high  spatial
resolution,  thus  prioritising  analysis  of  the  morphology  of  the  lesions  (the  contours,  form,
internal  characteristics)  [3,4], while  others  favoured  high  temporal  resolution,  preferring
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Figure 2. Aliasing artefact and compression because of poor coil
positioning. T2 TSE axial sequence with fat saturation: ghost images
in the phase encoding direction because of poor positioning of the
breast in the coil (folding in the outer quadrants) with lack of fat
saturation where there was contact with the coil.
Figure 3. Field non-uniformity artefact leading to non-uniformity
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ing  by  facilitating  detection  of  the  physiological  glandularTips  and  techniques  in  breast  MRI  
to  use  information  from  the  dynamic  enhancement  curve  of
the  lesions  [5,6]. Today,  with  technical  progress  these  two
approaches  are  reconciled,  and  this  compromise  is  the  basis
for  any  sequence  optimisation  in  breast  MRI.
Before beginning the examination. . .
Patient questionnaire
Apart  from  the  standard  contraindications  for  any  magnetic
imaging  examination  (heart  stimulator,  cochlear  implants,
ferromagnetic  aneurysm  clips,  etc.),  it  is  desirable  to  col-
lect  a  certain  amount  of  other  information  which  will  be
fundamental  for  interpreting  the  results  of  the  examination.
Before  the  examination,  it  is  helpful  to  have  the  patient
complete  a  speciﬁc  questionnaire  aided  by  an  experienced
breast  imaging  assistant  or  a  doctor.  This  should  include
information  on  hormonal  status  (menopause,  day  of  the
menstrual  cycle,  pregnancy,  breast-feeding),  the  personal
history  of  breast  cancer  (specifying  the  date  of  surgery,  the
date  of  the  end  of  radiotherapy,  the  history  of  axial  lymph
node  dissection,  the  chemotherapy  or  hormone  treatment)
and  any  family  history  (Appendix  A).
Positioning the coil
Correct  positioning  of  the  MRI  coil  is  essential  to  limit  a cer-
tain  number  of  artefacts  (Table  1).  The  patient  must  be  in  a
comfortable  position  with  her  arms  above  her  head  to  limit
aliasing  artefacts  and  artefacts  relating  to  phase  encoding
(Fig.  1).  In  order  to  limit  respiratory  movement  artefacts,
foam  wedges  should  be  used  inside  the  coil  when  the  breast
volume  is  low.  It  must  be  ensured  that  any  fold  that  could
form  when  the  breast  is  abnormally  compressed  by  the  edge
of  the  coil  is  avoided  (Fig.  2).  Attention  should  also  be  paid
to  correctly  positioning  the  nipple  directly  below  the  breast
to  facilitate  locating  lesions  and  make  it  easier  to  correlate
the  images  with  the  mammogram  and  ultrasound.
AcquisitionStandard protocol
In  order  to  optimise  image  quality,  it  is  necessary  to  observe
a  number  of  basic  points:
Figure 1. Motion artefacts. Because of poor uncomfortable positioning
the coil) visible on the T2-weighted sequences (a), the patient moved 
sequences particularly because of blurring in the phase encoding directif fat saturation. Saturation of the left breast has not occurred and
hat of the right breast is not uniform. This artefact is more common
n predominantly fatty breasts.
the  examination  must  be  performed  with  a  very  uniform
magnetic  ﬁeld  in  order  to  limit  artefacts  related  to  non-
uniform  fat  suppression  (Fig.  3)  [7];
both  breasts  must  be  investigated  to  allow  mirror  read- of the patient in the coil (external part of the left breast not within
during injection, which altered interpretation of the subtraction
on (b).
contrast  uptake,  which  can  limit  the  diagnostic  value  of
the  examination  by  masking  a  certain  amount  of  contrast
uptake  and  limiting  aliasing  artefacts  (this  occurs  when
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Table  1  The  main  artefacts  and  solutions  to  them.
Main  artefacts  Signs  Solutions
Movement  artefact Fuzzy  lines  Comfortable  position  for  the  patient
Propagation  in  the  phase  encoding  direction  Foam  wedges  in  the  coil  to  wedge  small  breasts
Enhancement  on  subtracted  sequences  not
found  on  native  sequences
Aliasing  artefact Ghost  images Increase  the  FOV
Modify  the  phase  encoding  direction
Magnetic  susceptibility
artefact
Tissue  distortion,  hypersignal  spots,  fall  in
signal
Reduce  the  TE
Non-uniformity  artefact  ofOccurs  with  a  non-uniform  ﬁeld  because  of Reshim  the  magnet
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the  marker  in  the  biopsy  site  at  the  end  of  the  procedure
[8].  When  the  biopsy  took  place  using  stereotaxic  mammog-
raphy  or  ultrasound,  the  marker  provides  conﬁrmation  that
the  position  of  the  biopsied  lesion  and  of  contrast  uptake  in
the  MRI  is  the  same.  This  detection  of  the  biopsy  marker  is
based  on  detecting  the  magnetic  susceptibility  artefact  on
T1  gradient-echo  sequences,  created  by  the  metallic  nature
of  the  marker.  The  longer  the  TE  of  the  sequence  the  more
this  artefact  is  visible.  As  a  corollary,  it  must  be  accompa-
nied  by  an  increase  in  TR  to  limit  the  loss  in  signal-to-noise
ratio.  If  a  satisfactory  compromise  is  not  found,  perform-
ing  two  T1  sequences  could  be  envisaged,  one  speciﬁcally
to  detect  the  metal  markers  and  the  second  to  characterise
the  T1  signal  of  the  lesions  (Fig.  4).
Figure 4. Special metal marker T1 sequences. The aim of this
sequence is to optimise visualisation of metal markers. It is a
T1 gradient-echo sequence for which the TE has been increasedfat  saturation non-selection  of  fatty  pixels
the  ﬁeld  of  view  is  smaller  than  the  area  of  the  patient
explored);
the  injection  of  gadolinium  must  be  reproducible  with  a
dose  of  0.1  mmol/kg  (or  0.2  mL/kg)  and  a  ﬂow  rate  of
1—2  mL/sec  ﬂushed  by  20  mL  of  physiological  saline.  The
use  of  an  automatic  injector  is  recommended;
slice  thickness  should  be  less  than  or  equal  to  3  mm  with
pixel  size  less  than  1  mm  on  each  side.  For  multiplanar
reconstruction,  the  voxel  should  optimally  be  isotropic
and  less  than  1  mm;
ﬁnally,  acquisition  time  should  be  less  than  2  minutes  as
the  mean  enhancement  time  of  a  malignant  tumour  is
between  90  and  120  seconds.
For  all  axial  plane  acquisitions  the  phase  encoding  direc-
ion  should  be  from  right  to  left  to  limit  artefacts  repeating
ardiac  and  respiratory  movement.  For  sequences  in  the
agittal  or  coronal  plane,  the  encoding  direction  will  be
nterior-posterior.
orphological  sequences
istorically,  breast  MRI  non-injected  sequences  were  con-
idered  as  being  of  little  use  because  of  the  low  diagnostic
alue  of  T2  and  T1-weighted  signals.  Since  then,  several
uthors  have  demonstrated  the  usefulness  of  T2-weighted
equences  for  detecting  the  presence  of  cysts  or  microcysts,
he  presence  of  which  suggests  the  benign  character  of
nhancement  (whether  annular  enhancement  in  the  case  of
n  inﬂammatory  cyst  or  stippled  non-masslike  enhancement
n  ﬁbrocystic  mastopathy).  The  European  recommendations
EUSOBI)  advocate  undertaking  a  T2-weighted  sequence.
ccording  to  Kuhl  et  al.,  T2-weighted  sequences  can  be  per-
ormed  without  fat  saturation  because  a  T2  signal  greater
han  that  of  non-saturated  fat  has  very  good  predictive  value
or  a  cyst  being  benign  [6].  T2-weighted  sequences  with  fat
aturation  are  useful  for  creating  indirect  MRI  ductography
mages  where  there  is  a  discharge  and  seem  to  optimise  the
etection  of  small  cancers.
T1-weighted  sequences  are  useful  for  detecting  the  pres-
nce  of  a  fatty  component  within  a  lesion,  which  is  also  a
ajor  aspect  predicting  its  benign  nature.  T1  sequences  areherefore  performed  without  fat  saturation.  They  also  allow
etal  markers  to  be  detected  which  may  have  been  pos-
tioned  at  the  end  of  biopsy.  When  the  biopsy  was  guided
y  MRI,  T1  sequences  can  conﬁrm  the  correct  position  of
to maximise the magnetic susceptibility effect. Mammogram pro-
duced after biopsy showing two markers (a). Breast MRI; T1 marker
sequence showing the two markers in the form of an absence of
signal with surrounding distortion (b).
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Figure 5. Comparison of a 3T and 1.5T acquisition in the same patient (same period of the cycle 1 month apart): a, b: comparison of
T2-weighted axial sequences on 1.5T (left) and 3T (right) machines; c, d: comparison of T1 GE 3D native axial sequences on 1.5T (left)
and 3T (right) machines; e, f: comparison of T1 GE 3D subtracted axial sequences on 1.5T (left) and 3T (right) machines. At 3T there is a
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Areduction in image quality, which usually occurs particularly on the
artefact as it can limit detection of lesions on subtracted sequence
Dynamic  sequences
Dynamic  sequences  must  satisfy  the  two  major  classic
requirements  of  perfusion  imaging:  good  temporal  resolu-
tion  (<  2  minutes)  and  good  spatial  resolution  (1  mm  isotropic
pixel).
2D  or  3D?
3D  T1  gradient-echo  sequences  with  a  moderate  ﬂip  angle
meet  these  requirements.  They  allow  thinner  slices  with  a
better  signal-to-noise  ratio  than  2D  sequences  [2].  However,
classically,  if  they  are  acquired  without  fat  suppression,  it
is  preferable  to  use  2D  sequences  to  limit  phase  encod-
ing  artefacts  which  propagate  in  all  three  directions  in  3D
sequences,  masking  the  contours  and  making  the  detection
of  these  artefacts  on  the  subtraction  sequences  difﬁcult.
What  plane  should  be  chosen?
Working  with  a  small  ﬁeld  of  view  is  possible  with  the  sagi-
ttal  plane  (which  means  a  gain  in  terms  of  spatial  resolution
and  ﬁeld  uniformity),  but  the  number  of  slices  needed  to
examine  the  two  breasts  means  that  it  is  essential  to  use
parallel  imaging  (or  SENSE)  to  have  an  acquisition  time  of
less  than  two  minutes.  Parallel  imaging  is  based  on  the
principle  of  partitioned  acquisition  of  the  ﬁeld  of  view
by  each  of  the  four  to  eight  coil  channels.  The  image  is
reconstructed  using  algorithms  which  are  very  sensitive  to
motion  artefacts,  particularly  in  sagittal  sequences.  For
m
w
a
i quadrants, because of non-uniformity of the ﬁeld. This is a major
his  reason,  axial  acquisitions  are  often  preferred.  In  an
xial  slice,  the  use  of  parallel  imaging  provides  improved
mage  quality  over  acquisitions  without  a  SENSE  factor
9].
hat  fat  suppression?
nitially,  the  use  of  subtractions  was  essential  for  detec-
ing  lesions  because  fat  suppression  was  too  costly  in  terms
f  time  to  be  performed.  With  the  arrival  of  parallel
maging,  native  sequences  can  be  acquired  with  fat  sat-
ration.  Undertaking  native  sequences  with  fat  saturation
aired  with  subtraction  improves  the  detection  of  lesions
nd  analysis  of  contrast  uptake  when  the  subtractions  are
egraded  by  movement.  There  are  several  fat  saturation
echniques:  the  classic  spectral  presaturation  with  inver-
ion  recovery  (SPIR)  fat  saturation  technique  has  now  been
eplaced  by  the  technique  of  selective  excitation  of  the
ater  peak,  which  gives  more  uniform  suppression  of  the
issues  and  improves  the  contrast  of  lesions  after  injection
10].
hat  are  the  beneﬁts  of  3T  imaging?
ppendix  B  shows  the  parameters  of  3D  sequences  opti-
ised  at  1.5  T  and  3  T.  They  are  applied  in  an  axial  plane
ith  a  short  TR  and  a  very  short  TE,  with  fat  saturation
llowing  easy  reading  of  the  native  sequences  and  reduc-
ng  artefacts  in  the  subtraction  sequences.  When  the  pixel
832  I.  Thomassin-Naggara  et  al.
Figure 6. Breast prosthesis sequences. STIR axial sequence with selective water suppression (a). T2 FSE axial sequence with selective
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water excitation (b). T2 TSE axial sequence with silicone suppressi
upture and no signs of extracapsular rupture (c).
s  isotropic,  dynamic  acquisitions  can  be  reduced  to  a  sin-
le  plane,  preferably  the  axial  plane,  since  multiplanar
econstruction  produces  satisfactory  images  in  the  sagittal
nd  coronal  planes.  Theoretically,  the  use  of  a  3T  mag-
et  increases  the  signal-to-noise  ratio.  Kuhl  et  al.  reported
mprovement  in  image  quality  because  of  possible  optimisa-
ion  of  the  spatial  resolution  with  a  3T  magnet  compared
ith  a  1.5T  magnet  [11]. In  our  experience,  the  use  of
T  MRI  for  breast  imaging  poses  the  major  problem  of
eld  uniformity  whereas  the  latter  is  essential  for  correct
at  suppression.  In  their  experience,  Kuhl  et  al.  reported
igniﬁcantly  lower  enhancement  levels  at  3T  than  were
btained  with  1.5T  acquisitions  (Fig.  5).  Our  clinical  impres-
ion  is  the  opposite,  with  enhancement  levels  which  seem
o  be  greater  at  3T  than  those  obtained  with  the  1.5T
agnet.  These  differences  from  the  results  of  Kuhl  et  al.
re  possibly  related  to  differences  in  sequences  used  on
he  Philips  magnet  because  we  used  a  new  3D  sequence
Appendix  B)  which  differed  from  the  2D  sequence  used
y  Kuhl  et  al.  in  their  ﬁrst  paper  [11]. In  addition,  in
ost  editorials  written  by  the  same  author,  she  advises
aution  and  warns  of  the  ﬁeld  uniformity  difﬁculties  inher-
nt  in  using  3T  for  the  breast.  Finally,  with  3T,  there  is
n  increase  in  artefacts,  whether  they  are  motion  arte-
acts  or  of  metal,  which  can  result  in  distortions  of  the
mage  which  adversely  affect  diagnosis  to  a  considerable
xtent.
Acquisition  is  ﬁrst  of  all  without  injection  (mask)  then
ynamic,  after  injection,  with  a  minimum  of  four  repeti-
ions  (the  minimal  number  of  points  for  the  enhancement
urve)  over  a  minimal  period  of  7  minutes.  Malignant
umours  enhance  within  1  minute  30  seconds  to  2  minutes
fter  injection.  Depending  on  the  acquisition  time  of
he  sequence,  a  period  of  about  20  seconds  may  be  left
etween  the  end  of  the  injection  and  the  start  of  the
ynamic  sequences  so  that  the  ﬁrst  acquisition  is  at
he  point  of  maximum  uptake  of  contrast  by  malignant
esions.
N
o
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c a patient with prepectoral prostheses with bilateral intracapsular
peciﬁcities of the protocol depending on the
linical indication
reast  implants
he  image  acquisition  protocol  must  include  a sequence
here  fat  and  silicone  are  in  hypersignal  (T2  TSE  with
elective  water  suppression;  detection  of  an  intracapsular
upture),  a  sequence  where  only  the  silicone  is  in  hyper-
ignal  (water  and  fat  saturation  with  a  STIR  sequence  with
elective  water  suppression;  detection  of  an  extracapsu-
ar  rupture)  and  ﬁnally  a  sequence  saturating  the  silicone
water  and  fat  in  hypersignal  with  a  T2  TSE  with  selec-
ive  silicone  suppression;  detection  of  a periprosthetic  liquid
ffusion).  Fat  suppression  is  preferably  achieved  with  the
TIR  sequence  because  the  silicone  and  fat  peaks  are
lose  together,  which  prevents  correct  fat  suppression  by
 method  involving  selective  suppression  of  the  peak.  This
TIR  sequence  produces  the  best  contrast  with  adjacent  tis-
ues  (which  is  fundamental  for  detecting  an  extracapsular
upture).  On  the  other  hand,  analysis  of  the  content  of  the
mplant  is  less  precise  than  with  the  T2  TSE  sequence  with
ater  suppression,  which  is  still  necessary  for  detecting  and
nalysing  an  intracapsular  rupture  [12]. Acquisition  is  in  the
xial  and  sagittal  planes  (Fig.  6).
reast  discharge
2-weighted  sequences,  with  fat  saturation  and  without
he  use  of  a  contrast  agent,  produce  an  ‘indirect’  duc-
ography  image  of  the  dilated  lactiferous  ducts,  which
ppear  in  T2  hypersignal  relative  to  the  saturated  fat,
hereas  the  mammary  tissue  is  in  hyposignal  (Fig.  7).  Some
eams  have  suggested  performing  direct  MR  ductography,
hich  consists  of  injecting  gadolinium  (gadopentate,  MAG-
EVIST)  into  the  lactiferous  ducts  then  performing  VIBE
r  FLASH  rapid  sequences,  depending  on  the  constructors.
hen  conventional  ductography  has  failed,  this  technique
ould  thus  provide  an  alternative  for  identifying  and  then
Tips  and  techniques  in  breast  MRI  
Figure 7. The usefulness of T2-weighted sequences with fat sat-
uration in cases of nipple discharge. T2 TSE axial sequence with
fat saturation showing predominant unilateral duct ectasia at the
junction of the inner quadrants of the right breast in a patient with
juvenile papillomatosis or ‘‘Swiss cheese disease’’.
t
o
p
d
d
P
A
M
T
a
p
o
m
n
t
t
l
Figure 8. Multiplanar reconstruction. Isotropic axial sequences (a) a
equivalent to acquisition in the native plane (c). This reconstruction is
correlating MRI data with the data of the mammogram or mammary ultr833
argeting  a  breast  abnormality  for  undertaking  a  biopsy
r  pinpointing  it  preoperatively.  In  a  population  of  62
atients  referred  for  nipple  discharge,  this  technique  pro-
uced  diagnostic  accuracy  close  to  that  of  conventional
uctography  (85%)  [13].
ost-treatment
nalysis of the morphology of the lesions
ultiplanar  reconstruction
his  is  one  of  the  fundamental  phases  of  the  examination,
llowing  lesions  to  be  located  in  the  three  axes.  It  is  thus
articularly  useful  for  analysing  the  shape  and  contours
f  a  mass,  and  the  distribution  of  non-masslike  enhance-
ent  by  providing  its  possible  orientation  relative  to  the
ipple,  for  calculating  the  distance  to  the  nipple  from
he  area  of  contrast  uptake,  for  evaluating  possible  pec-
oral  extension  or  determining  the  quadrant  in  which  the
esion  is  situated  (making  the  task  easier  for  second-line
llow multiplanar reconstruction of excellent quality (b), virtually
 very useful for assessing distance relative to the nipple and for
asound (quadrant on coronal reconstructions) (d).
834  I.  Thomassin-Naggara  et  al.
Figure 9. Usefulness of multiple intensity projection (MIP). Patient with a multifocal ductal carcinoma visible on early subtracted
sequences after injection of gadolinium (a). MIP reconstruction in the axial plane maximises contrast uptake (b) and in the sagittal plane
shows the extension of tumour formations (c).
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•ltrasonography  looking  for  the  lesions  detected  by  MRI)  [14]
Fig.  8).
ultiple  intensity  projection  (MIP)
his  rapidly  detects  areas  of  maximum  enhancement  (a
umour,  a  lymph  node)  and  their  relationship  with  the  arter-
es  or  veins  (Fig.  9).  It  must  be  undertaken  from  early
ynamic  sequences  following  injection  of  gadolinium.  It  can
e  useful  to  the  surgeon  if  there  are  multiple  lesions  for
ssessing  the  relations  of  each  of  the  lesions.  On  the  other
and,  in  no  case  can  it  be  used  for  measurement  (particu-
arly  not  for  measuring  distance  relative  to  the  nipple).
nalysis of enhancement dynamics
n  contrast  enhanced-MRI,  the  principle  is  common  to
ll  tissues:  the  slice  is  selected  where  the  tissue  to  be  stud-
ed  is  located,  then  areas  of  interest  to  be  analysed  are
ositioned.  The  correct  position  of  the  area  of  interest
ithin  the  enhancement  area  on  the  different  acquisi-
ion  phases  must  be  systematically  checked.  If  an  area  of
nhancement  is  detected  on  subtracted  sequences,  analy-
is  of  the  enhancement  dynamics  should  be  conﬁrmed  on
he  native  sequences  to  eliminate  all  artefacts  linked  to  the
ubtraction  (Fig.  10).  Several  types  of  analysis  of  contrast
ptake  can  be  performed:descriptive  analysis  is  the  simplest  and  consists  of  describ-
ing  types  of  curves  (type  1  benign,  progressive,  type  2
intermediate  with  a  plateau,  or  type  3  malignant,  with
secondary  washout);
semi-quantitative  analysis  involves  determining  more
reproducible  parameters  describing  the  enhancement
curve,  such  as  the  initial  enhancement  slope,  the  time
to  peak,  washout  and  the  area  under  the  curve.  These
parameters  are  the  basis  for  the  colour-coded  parametric
maps  offered  by  various  constructors  or  CAD  programs.
Thus  there  are  maps  of  washin,  washout,  a  combination
of  the  two,  time  to  peak  or  of  area  under  the  curve.  These
maps  can  help  detect  maximum  areas  of  contrast  uptake
in  order  to  determine  regions  where  an  area  of  interest
should  be  applied  (Fig.  11);
quantitative  analysis,  the  last  type  of  analysis,  is  based
on  compartmental  analysis.  The  principle  of  this  analysis
is  to  follow  the  changes  in  concentration  of  the  contrast
agent  in  each  tissue  compartment  using  differential  equa-
tions  which  deﬁne  the  compartmental  model  used.  In
breast  imaging,  the  most  commonly  used  model  is  the
extended  Tofts-Kety  model  [15]. It  is  suitable  for  low
temporal  resolution  acquisitions  because  it  uses  a  mean
arterial  input  function.  It  describes  the  blood  volume,
the  interstitial  volume  and  a  transfer  constant  between
these  two  compartments  (Ktrans).  Quantitative  analysis  is
the  most  reproducible  analysis  because,  unlike  the  ﬁrst
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Figure 10. Subtraction artefact. Subtraction image between the native image 1 minute after injection of gadolinium and acquisition
without injection: presence of regional non-masslike enhancement of the UOQ of the left breast and prepectoral contrast uptake (a). T1
Fat Sat gradient-echo native image without injection of gadolinium (b). Native image following injection of gadolinium in T1 gradient-echo
with fat saturation showing the absence of signiﬁcant contrast uptake and a slightly different position of the breast indicating movement
between the two acquisitions (c). In addition, there is contraction of the pectoral muscle creating false uptake of contrast in the deep part
of the breast. Re-reading native sequences is therefore useful after detecting contrast uptake on subtracted sequences when an artefact is
suspected.
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btwo  analyses,  it  is  independent  of  measurement  condi-
tions  (sequence,  machine,  coil,  etc.).  However,  this  type
of  post-treatment  is  still  in  the  development  stage  even  if
some  semi-automatic  programs  are  beginning  to  appear.
Work in progress: diffusion and
spectroscopy
The  sensitivity  of  breast  MRI  is  excellent  (higher  than  95%
for  invasive  carcinomas)  but  its  speciﬁcity  is  very  variable
depending  on  the  experience  of  the  reader  (37  to  86%
depending  on  the  study,  according  to  the  literature)  despite
the  different  multiparametric  approaches  which  take  into
account  both  morphological  and  dynamic  criteria  [6,16,17].
Several  techniques  are  also  currently  being  developed  in  an
attempt  to  increase  the  speciﬁcity  of  this  examination.
Magnetic resonance spectroscopyMagnetic  resonance  spectroscopy  (1H  MR  spectroscopy)
is  a  molecular  imaging  method  based  on  detecting  an
abnormal  choline  peak  in  malignant  tumours  (resonance
p
c
e
ot  3.2  ppm)  [18]. Bartella  et  al.  have  shown  that  adding
his  sequence  to  the  standard  protocol  increases  the  PPV
f  biopsies  from  35  to  82%  (P  <  0.01)  and  avoids  a  biopsy
n  57%  of  lesions  without  any  cancer  going  unrecognised.
19].  In  addition,  several  preliminary  studies  have  recently
emonstrated  the  usefulness  of  this  imaging  technique  for
howing  up  an  early  response  (after  24  hours)  to  neoadjuvant
hemotherapy  [20]. There  are  two  broad  types  of  anal-
sis  technique:  monovoxel  acquisition,  targeted  on  the
esion  enhancing  after  gadolinium  injection,  is  the  most
idespread.  Few  studies  have  produced  acceptable  results
ith  multivoxel  sequences  because  the  signal-to-noise  ratio
t  1.5T  is  too  low.  Additional  studies  will  be  necessary  with
he  development  of  3T  magnets.  Of  the  sequences  avail-
ble,  the  Point  REsolved  Spectroscopy  Sequence  (PRESS)
s  usually  preferred  because,  for  the  breast,  it  pro-
ides  a better  signal-to-noise  ratio  than  the  STimulated
cho  Acquisition  Mode  (STEAM)  sequence.  Acquisition  takes
etween  6  and  12  minutes  with  a  5-minute  preparation
hase,  allowing  shimming,  to  check  the  homogeneity  of  the
oil.  Any  difﬁculty  is  in  post-treatment  which  requires  an
xpert  in  spectroscopy  to  interpret  the  molecular  proﬁles
btained.
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Figure 11. Semi-quantitative analysis of gadolinium contrast uptake. Detection of contrast uptake on subtraction sequences. Parametric
mapping reﬂects washin allowing the areas of maximum enhancement (red) to be selected (a). A dynamic enhancement curve against time
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iffusion
iffusion  imaging  is  a  method  based  on  quantiﬁcation  of  the
otion  of  water  molecules  in  the  tissues.  There  are  two
bjectives  in  using  diffusion  sequences:  to  optimise  charac-
erisation  of  lesions  (to  differentiate  benign  from  malignant
umours)  and  to  improve  detection  of  small  lesions,  which
equires  an  optimal  signal-to-noise  ratio.  It  has  been  shown
n  breast  imaging  that  there  is  a  reduction  in  the  appar-
nt  diffusion  coefﬁcient  (ADC)  in  malignant  tumours  with  a
hreshold  value  of  1.13  ×  103 mm2/s  [21]. The  ADC  of  malig-
ant  tumours  is  between  0.95  and  1.02  ×  10−3 mm2/s,  of
enign  tumours  between  1.35  and  1.66  ×  10−3 mm2/s  and  of
ormal  tissue  between  1.51  and  1.9  ×  10−3 mm2/s.  A  wide
ariety  of  ADC  values  can  be  found  in  the  literature  [22].
hen  combined  with  morphological  data  and  the  type  of
nhancement,  this  technique  allows  breast  MRI  to  achieve
iagnostic  accuracy  of  91%  [23]. Initially,  diffusion  was
ainly  assessed  for  masses  larger  than  1  cm  [24,25]  but  with
he  recent  technical  improvements,  several  authors  have
hown  that  this  technique  is  relevant  for  smaller  masses
w
(
p
ffore injection (b).
5  mm)  and  even  for  non-masslike  enhancements  [26,27].
t  3T,  there  is  no  difference  in  value  of  the  ADC  coefﬁcients
ut  small  lesions  are  detected  better  as  there  is  a  better
ignal-to-noise  ratio  which  is  optimal  for  a  b value  of  850
28].  Nothing  is  gained  by  increasing  the  b  values  above
000  because  the  signal-to-noise  ratio  falls.  Two  b  values  are
nough  to  calculate  a  correct  ADC.  At  1.5T  this  is  the  pair  0
nd  750  [29]  and  at  3T  the  pair  50  and  850  [28]. Diffusion  MRI
eems  also  to  be  of  use  for  evaluating  the  response  to  neoad-
uvant  chemotherapy  with  a  rise  of  more  than  10%  in  the  ADC
oefﬁcients  at  the  end  of  the  ﬁrst  cycle  of  chemotherapy
30].  Certain  authors  have  shown  that  the  mean  ADC  value
efore  neoadjuvant  chemotherapy  could  be  a  good  predic-
ive  factor  of  response  to  the  treatment  [31]. This  was  a
reliminary  study  which  must  be  conﬁrmed  on  larger  series.
 recent  study  has  shown  the  usefulness  of  diffusion  imaging
or  differentiating  between  tumour  recurrence  and  scarring,
hich  is  one  of  the  classic  questions  asked  in  breast  MRI
Fig.  12)  [32]. Finally,  the  diffusion  tensor  provides  a  new
arameter  predicting  malignancy  independent  of  the  ADC:
ractional  anisotropy  [26].
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Figure 12. Diffusion sequence at 1.5T. T2-weighted sequence (a). Dynamic sequence with injection (2nd phase after injection): presence
of architectural disorganisation due to a history of surgery without detectable suspect contrast uptake (b). b750 weighted diffusion sequence
showing the absence of a hypersignal anomaly in the scar area (c). There is a hypersignal in front of the scar which is a T2 shine-through
fﬁcieffect (no lowering of the apparent diffusion coefﬁcient [ADC] coe
absence of evidence of tumour recurrence (d).
Disclosure of interestThe  authors  declare  that  they  have  no  conﬂicts  of  interest
concerning  this  article.ent). ADC map showing an ADC coefﬁcient of 1.34 conﬁrming the
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ppendix A. Example of MRI questionnaire developed by the CHUM
ave you already had breast MRI: No Yes Where? When?
ate of your last mammogram:
.  If  you  are  not  post-menopausal,  which  of  these  options  describes  your  situation?
Regular  menstrual  cycle. .  .. .  .. .  .. .  .. .  .. Date  of  the  1st  day  of  your  last  period:
Irregular  menstrual  cycle. .  .. .  .. .  .. .  .. .  .  Date  of  the  1st  day  of  your  last  period:
Hysterectomy  with  one  or  two  ovaries  in  place
Are  you  taking  oral  contraceptives? No  Yes  Which  and  since  when?
.  If  you  are  post-menopausal,  please  give  us  the  following  information:
1. Natural  menopause. .  .. .  .. .  .. .  .. .  .. .  .. .  .. .  .. .  .. .  .. .  .. . .. .  .At what  age:
2. Surgical  menopause  (bilateral  ovariectomy)  . .  .. .  .. . .How  many  years  ago
3. Menstrual  cycle  stopped  by  chemotherapy.  .  .. .  .. .  .. . .Date  of  last  period:
Are  you  taking  hormones?  Yes,  which  and  since  when?
No,  never  taken  OR  No,  stopped  since:
e  would  like  to  know  your  personal  medical  history:
To  which  category  do  you  belong?
A.  Never  been  diagnosed  as  having  breast  cancer
B.  Breast  cancer  already  diagnosed  Date:
Site:  Right  Left
Treatment:  1.  Surgery  Date  of  surgery:
Partial  Total  Prosthesis  reconstruction  TRAM
2.  Radiotherapy  Conventional  OR  Brachytherapy
3.  Chemotherapy
If  treatment  is  on-going,  please  tell  us  the  treatment  you  have  already  received:
4.  Have  you  had  axillary  or  sentinel  lymph  node  dissection?
Yes,  number  of  lymph  nodes  affected:  No
Are  you  taking  tamoxifen,  Arimidex  or  other  anti-oestrogens?
Yes,  since  when?
No
.  Have-you  already  had  mediastinal  radiotherapy  (e.g.  for  a  lymphoma)?
.  What  is  your  family  medical  history?
reast  cancer  Ovarian  cancer
Mother  age:  Daughter  age:  Mother  age:  Daughter  age:
Sister  age:  Aunt  age:  Sister  age:  Aunt  age:
Others:  Others:
Please  give  us  the  name  of
Your  family  doctor:  Your  surgeon/oncologist:
ppendix B. Optimised sequence parameters (GE, Siemens, Philips)
GE  (1.5T)  Siemens  (1.5T)  Philips  (1.5T)  Philips  (3T)
ame  SPGR  fat  sat  3D  FLASH  3D  3D  THRIVE  3D  THRIVE
R  6.2  10  5.4  4.4
E  3  4.8  2.7  2.2
ngle  15  12  12  12
atrix  350  ×  350  307  ×  512  400  ×  397  220  ×  230
OV  35  40  32  22
OV  phase  1  1  1  1
ex 1  1  1  1
W  (Hz)  41.65  81.5  358.4  132.3
ENSE 2  2  3  2
oxel 1  × 1 ×  1  1  ×  1  ×  1  0.8  ×  0.8  ×  0.8  1 ×  1  ×  1
lice  thickness 2  mm 1  mm 1.6  mm  2
uration  (sec) 81  82  81  51
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